Form 4: Nuvalent CFO Alexandra Balcom Executes Stock Option and Sells Shares Under 10b5-1 Plan

Alexandra Balcom, CFO of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on September 30, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 30, 2024, Alexandra Balcom, the Chief Financial Officer of Nuvalent, Inc., executed a stock option to purchase 10,000 shares of Class A Common Stock at a price of $27.85 per share.
• Simultaneously, Balcom sold a total of 10,000 shares of Class A Common Stock in multiple transactions at weighted average prices ranging from $98.88 to $101.89.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 28, 2023.
• Following these transactions, Balcom directly owns 33,300 shares of Class A Common Stock and 104,200 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan. It doesn't inherently indicate positive or negative news about the company's performance.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which is generally viewed as a transparent and compliant way for insiders to manage their stock holdings.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests the transactions were planned and not based on inside information.

Key Dates